PDX Biotech
Early Stage
Rapid Test For Periodontal Disease
Overview
Raised: $147,400
Total Commitments ($USD)
Platform
StartEngine
Start Date
08/14/2022
Close Date
12/13/2022
Min. Goal
$10,000
Max. Goal
$1,070,000
Min. Investment
$100
Security Type
Equity - Common
Series
Pre-Seed
SEC Filing Type
RegCF
Price Per Share
$20.00
Pre-Money Valuation
$3,210,000
Rolling Commitments ($USD)
Status
Funded
Reporting Date
12/30/2022
Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise
$1,228
# of Investors
36
Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded
2019
Industry
Pet Health, Food, and Services
Tech Sector
HealthTech
Distribution Model
B2C
Margin
Medium
Capital Intensity
Low
PDX Biotech, with a valuation of $3.21 million, is raising funds on StartEngine. The company has developed a rapid test to detect periodontal disease in cats and dogs. The test, OraStripdx, is sold to veterinary teams and used to detect the bacteria that cause periodontal disease within ten seconds. The use of OraStripdx does not require anesthesia or sedation and provides visual evidence to support veterinary team recommendations. PDX Biotech has already sold over 100,000 tests to customers in the US, Europe, Asia, and South America. David McClure and Tony Burgess-Cassler founded PDX Biotech in December 2019. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1,070,000. The campaign proceeds will be used for growth and expansion.
Summary Profit and Loss Statement
| Most Recent Year | Prior Year | |
|---|---|---|
|
Revenue |
$37,090 |
$31,675 |
|
COGS |
$19,199 |
$16,934 |
|
Tax |
$0 |
$0 |
| ||
| ||
|
Net Income |
$-16,487 |
$-768 |
Summary Balance Sheet
| Most Recent Year | Prior Year | |
|---|---|---|
|
Cash |
$3,103 |
$45 |
|
Accounts Receivable |
$0 |
$0 |
|
Total Assets |
$6,630 |
$4,081 |
|
Short-Term Debt |
$0 |
$0 |
|
Long-Term Debt |
$0 |
$0 |
|
Total Liabilities |
$0 |
$0 |
Financials as of: 08/14/2022
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Already a member? Log in here.
Ratings 
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.